share_log

CRISPR Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Bruno Julianne

SEC announcement ·  May 24 04:32
Summary by Futu AI
Julianne Bruno, Chief Operating Officer of CRISPR Therapeutics, filed an Initial Statement of Beneficial Ownership of Securities with the SEC on May 23, 2024. The filing, required under Section 16(a) of the Securities Exchange Act of 1934, details Bruno's direct and indirect ownership of CRISPR Therapeutics' common shares and derivative securities, including stock options and restricted stock units (RSUs). Bruno directly owns 3,111 common shares and indirectly owns 7,088 shares through the Julianne Bruno 2022 GRAT. The filing also lists multiple stock options with varying exercise prices and expiration dates, ranging from May 1, 2029, to March 20, 2034, and RSUs with vesting schedules extending to March 20, 2028. The document outlines the vesting conditions of these securities, indicating a structured plan for share ownership over the coming years.
Julianne Bruno, Chief Operating Officer of CRISPR Therapeutics, filed an Initial Statement of Beneficial Ownership of Securities with the SEC on May 23, 2024. The filing, required under Section 16(a) of the Securities Exchange Act of 1934, details Bruno's direct and indirect ownership of CRISPR Therapeutics' common shares and derivative securities, including stock options and restricted stock units (RSUs). Bruno directly owns 3,111 common shares and indirectly owns 7,088 shares through the Julianne Bruno 2022 GRAT. The filing also lists multiple stock options with varying exercise prices and expiration dates, ranging from May 1, 2029, to March 20, 2034, and RSUs with vesting schedules extending to March 20, 2028. The document outlines the vesting conditions of these securities, indicating a structured plan for share ownership over the coming years.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.